These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 10965287

  • 1. Reducing relapse in depressed outpatients with atypical features: a pilot study.
    Jarrett RB, Kraft D, Schaffer M, Witt-Browder A, Risser R, Atkins DH, Doyle J.
    Psychother Psychosom; 2000; 69(5):232-9. PubMed ID: 10965287
    [Abstract] [Full Text] [Related]

  • 2. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
    Jarrett RB, Schaffer M, McIntire D, Witt-Browder A, Kraft D, Risser RC.
    Arch Gen Psychiatry; 1999 May; 56(5):431-7. PubMed ID: 10232298
    [Abstract] [Full Text] [Related]

  • 3. Can mildly depressed outpatients with atypical depression benefit from antidepressants?
    Stewart JW, McGrath PJ, Quitkin FM.
    Am J Psychiatry; 1992 May; 149(5):615-9. PubMed ID: 1575250
    [Abstract] [Full Text] [Related]

  • 4. Quantifying and qualifying the preventive effects of acute-phase cognitive therapy: Pathways to personalizing care.
    Jarrett RB, Minhajuddin A, Vittengl JR, Clark LA, Thase ME.
    J Consult Clin Psychol; 2016 Apr; 84(4):365-76. PubMed ID: 26654211
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. How much cognitive therapy, for which patients, will prevent depressive relapse?
    Jarrett RB, Vittengl JR, Clark LA.
    J Affect Disord; 2008 Dec; 111(2-3):185-92. PubMed ID: 18358541
    [Abstract] [Full Text] [Related]

  • 9. Longitudinal social-interpersonal functioning among higher-risk responders to acute-phase cognitive therapy for recurrent major depressive disorder.
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    J Affect Disord; 2016 Jul 15; 199():148-56. PubMed ID: 27104803
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: a randomized controlled trial.
    Nordenskjöld A, von Knorring L, Ljung T, Carlborg A, Brus O, Engström I.
    J ECT; 2013 Jun 15; 29(2):86-92. PubMed ID: 23303421
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A pilot sequential study of cognitive therapy and pharmacotherapy of atypical depression.
    Mercier MA, Stewart JW, Quitkin FM.
    J Clin Psychiatry; 1992 May 15; 53(5):166-70. PubMed ID: 1592844
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.